Search Ontology:
ChEBI
GSK-J4
- Term ID
- CHEBI:95077
- Synonyms
-
- 3-[[2-(2-pyridinyl)-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)-4-pyrimidinyl]amino]propanoic acid ethyl ester
- ethyl 3-((2-(pyridin-2-yl)-6-(1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)pyrimidin-4-yl)amino)propanoate
- ethyl N-[2-(pyridin-2-yl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)pyrimidin-4-yl]-beta-alaninate
- Definition
- A member of the class of aminopyrimidines that is pyrimidine substituted by pyridin-2-yl, 3-ethoxy-3-oxopropylamino, and 1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl groups at positions 2, 4, and 6, respectively. It is an inhibitor of the histone demethylase JMJD3/UTX.
- References
-
- CAS:1373423-53-0
- HMDB:HMDB0252948
- LINCS:LSM-6328
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from GSK-J4
Phenotype where environments contain GSK-J4
Phenotype modified by environments containing GSK-J4
Phenotype affecting GSK-J4
Human Disease Model